OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES

JK Choi, W **ao, X Chen, S Loghavi… - Modern Pathology, 2024 - Elsevier
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …

Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium

CC Chan, JL Rubenstein, SE Coupland… - The …, 2011 - academic.oup.com
Primary vitreoretinal lymphoma (PVRL), also known as primary intraocular lymphoma, is a
rare malignancy typically classified as a diffuse large B‐cell lymphoma and most frequently …

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

AJ Souers, JD Leverson, ER Boghaert, SL Ackler… - Nature medicine, 2013 - nature.com
Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic
process. This family comprises proapoptotic and prosurvival proteins, and shifting the …

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide …

TM Green, KH Young, C Visco… - Journal of clinical …, 2012 - ascopubs.org
Purpose Approximately 5% of diffuse large B-cell lymphomas (DLBCLs) are double-hit
lymphomas (DHLs) with translocations of both MYC and BCL2. DHLs are characterized by …

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

RD Morin, NA Johnson, TM Severson, AJ Mungall… - Nature …, 2010 - nature.com
Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL)
derive from germinal center B cells. Targeted resequencing studies have revealed mutations …

Stromal gene signatures in large-B-cell lymphomas

G Lenz, G Wright, SS Dave, W **ao… - … England Journal of …, 2008 - Mass Medical Soc
Background The addition of rituximab to combination chemotherapy with
cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has …

The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo

FA Karreth, M Reschke, A Ruocco, C Ng, B Chapuy… - Cell, 2015 - cell.com
Research over the past decade has suggested important roles for pseudogenes in
physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to …

Deletions linked to TP53 loss drive cancer through p53-independent mechanisms

Y Liu, C Chen, Z Xu, C Scuoppo, CD Rillahan, J Gao… - Nature, 2016 - nature.com
Mutations disabling the TP53 tumour suppressor gene represent the most frequent events in
human cancer and typically occur through a two-hit mechanism involving a missense …

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

G Lenz, GW Wright, NCT Emre… - Proceedings of the …, 2008 - National Acad Sciences
Gene-expression profiling has been used to define 3 molecular subtypes of diffuse large B-
cell lymphoma (DLBCL), termed germinal center B-cell-like (GCB) DLBCL, activated B-cell …

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling

M Hummel, S Bentink, H Berger… - … England Journal of …, 2006 - Mass Medical Soc
Background The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma
is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more …